Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning

Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SATHYAN GAYATRI, DAVAR NIPUN, HASTEDT JAYNE, PORS LINDA HEARNEY, CASADEVALL GEMMA
Format: Patent
Sprache:nor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SATHYAN GAYATRI
DAVAR NIPUN
HASTEDT JAYNE
PORS LINDA HEARNEY
CASADEVALL GEMMA
description Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20064997LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20064997LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20064997LL3</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeodxgMIRUXpWiwuim7cl8H8tsEkU5K0eHzT4gHczIf_3p9l9ik9bMuuDZYjqBFPHmoI8Nq1xCOxeUsnRru5jKQkYIhRrJ2EyZdei1Yg8Www82kbErLwZKHIpP8je538dPToEl9ni4ZNwOaXq2xbXp-X2w691Ag9v-AQ6_tjn-enY1Gcq-rwj_MF0O9IjQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><source>esp@cenet</source><creator>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</creator><creatorcontrib>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</creatorcontrib><description>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</description><language>nor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070502&amp;DB=EPODOC&amp;CC=NO&amp;NR=20064997L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070502&amp;DB=EPODOC&amp;CC=NO&amp;NR=20064997L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SATHYAN GAYATRI</creatorcontrib><creatorcontrib>DAVAR NIPUN</creatorcontrib><creatorcontrib>HASTEDT JAYNE</creatorcontrib><creatorcontrib>PORS LINDA HEARNEY</creatorcontrib><creatorcontrib>CASADEVALL GEMMA</creatorcontrib><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><description>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeodxgMIRUXpWiwuim7cl8H8tsEkU5K0eHzT4gHczIf_3p9l9ik9bMuuDZYjqBFPHmoI8Nq1xCOxeUsnRru5jKQkYIhRrJ2EyZdei1Yg8Www82kbErLwZKHIpP8je538dPToEl9ni4ZNwOaXq2xbXp-X2w691Ag9v-AQ6_tjn-enY1Gcq-rwj_MF0O9IjQ</recordid><startdate>20070502</startdate><enddate>20070502</enddate><creator>SATHYAN GAYATRI</creator><creator>DAVAR NIPUN</creator><creator>HASTEDT JAYNE</creator><creator>PORS LINDA HEARNEY</creator><creator>CASADEVALL GEMMA</creator><scope>EVB</scope></search><sort><creationdate>20070502</creationdate><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><author>SATHYAN GAYATRI ; DAVAR NIPUN ; HASTEDT JAYNE ; PORS LINDA HEARNEY ; CASADEVALL GEMMA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20064997LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SATHYAN GAYATRI</creatorcontrib><creatorcontrib>DAVAR NIPUN</creatorcontrib><creatorcontrib>HASTEDT JAYNE</creatorcontrib><creatorcontrib>PORS LINDA HEARNEY</creatorcontrib><creatorcontrib>CASADEVALL GEMMA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SATHYAN GAYATRI</au><au>DAVAR NIPUN</au><au>HASTEDT JAYNE</au><au>PORS LINDA HEARNEY</au><au>CASADEVALL GEMMA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning</title><date>2007-05-02</date><risdate>2007</risdate><abstract>Metoder for tilførsel av opioider med langvarig frigivelse, inklusive, men ikke begrenset til, hydromorfon og oksykodon som fremviser forbedrede egenskaper i forbindelse med samtilførsel med vandig alkohol. Oral dosage form comprises an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of the mean unit dose maximum opioid plasma concentration with alcohol coadminstration to the mean unit dose maximum opioid plasma concentration without alcohol co-adminstration is no more than 1.8:1. Independent claims are also included for: (1) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that the ratio of an individual patient unit dose maximum opioid plasma concentration with alcohol coadminstration to the individual unit dose maximum opioid plasma concentration without alcohol coadminstration is no more than 5:1; (2) oral dosage form comprising an opioid and a dosing structure that provides extended release of the opioid in the presence of aqueous alcohol with an alcohol concentration of at least 20 vol.%, such that no more than 80% of the dose is released in 2 hours in an in-vitro test performed in the presence of at least 20 vol.% alcohol. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language nor
recordid cdi_epo_espacenet_NO20064997LL
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A57%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SATHYAN%20GAYATRI&rft.date=2007-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20064997LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true